UCB and Biogen Idec enter agreement to commercialize multiple sclerosis and hemophilia therapies in Asia
- Details
- Category: UCB

Pfizer reports fourth-quarter and full-year 2013 results
- Details
- Category: Pfizer

Novartis recognized among world's most sustainable companies in Corporate Knights Global 100
- Details
- Category: Novartis

Bristol-Myers Squibb Reports fourth quarter and full year 2013 financial results
- Details
- Category: Bristol-Myers Squibb

Abbott reports fourth-quarter and full-year 2013 results
- Details
- Category: Abbott

AstraZeneca and Bristol-Myers Squibb Diabetes Alliance provides $5 million grant for American Diabetes Association's Pathway to Stop Diabetes
- Details
- Category: Bristol-Myers Squibb

Tafinlar® receives FDA Breakthrough Therapy designation for non-small cell lung cancer with BRAF mutation
- Details
- Category: GlaxoSmithKline

More Pharma News ...
- MedImmune and Immunocore enter immunotherapy agreement to develop novel cancer therapies
- Bayer and Peking University establish new research center for translational research and drug discovery in Beijing
- GSK adds detailed clinical trial data to multi-sponsor request system
- Bayer plans to acquire Norwegian pharmaceutical company Algeta
- Bristol-Myers Squibb to sell its global diabetes business
- Pfizer settles Viagra® patent litigation with Teva
- Lundbeck and Otsuka to co-develop Lu AF20513, an investigational vaccine against Alzheimer's disease